PDC Therapeutics

Private

EpalingesHealthcare & Life Scienceshttps://pdcbio.com/

Last Round

Series A

Dec 15, 2021

Total Funding Raised

$14.2M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

PDC Therapeutics is a biotechnology company that develops targeted Polymer-Drug Conjugate technologies for cancer therapies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine, Advanced Materials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

polymer-drug conjugatePDCdrug delivery platformnanomedicinetargeted drug deliverytargeted chemotherapyoncologyclinical-stage biotechdrug conjugatedrug co-developmentsolid tumorsdocetaxel conjugateradioligand therapyRLTtheranostics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

PDC Therapeutics Comps

Public and private peers based on sector, stage, and business model.

PDC Therapeutics comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

PDC Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Dec 15, 2021

View all Funding Rounds

Key People

Founding team and executive leadership

Sena Nomak

Co-Founder COO

Founding Team

PDC Therapeutics Investors

Notable investors and investment history

PDC Therapeutics investors
Investor	Rounds
ACT Venture Partners	Seed
İstanbul Portföy Yönetimi	Series A

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

May 11, 2026
Monthly visitors increased 374% MoM, from 358 to 1.7K.
May 1, 2025
Monthly visitors increased 156% MoM.

View all signals

PDC Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

PDC Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about PDC Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersEpalinges

Employee Range6

Year Founded2020

Last FundingDec 15, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.